Janet Sue Ramsey, LCSW-C Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: Bldg 361, Perry Point Medical Center, Perry Point, MD 21902 Phone: 410-642-2411 Fax: 410-642-1825 |
Mr. Alan Sutton Brett, MA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: Building 80h (pp-116b), Vamc, Perry Point, MD 21902 Phone: 410-642-2411 Fax: 410-642-1101 |
Alexandra Maria Wilson, LMSW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 601 Perryville Dr Bldg 22, Perry Point, MD 21902 Phone: 410-642-2411 |
Dr. John Robert Richardson, MS, D.MIN. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: Pp/125 Building 314 Room C106, Va Medical Center - Perry Point Div, Perry Point, MD 21902 Phone: 410-642-1037 Fax: 410-642-1843 |
Jane Manlove, MSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: Bldg 366 Rm 151, Vamhcs, Perry Point, MD 21902 Phone: 410-642-2411 |
Mr. Dale Edward Smith, M.A. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: Va Medical Center, Perry Point, 1h Circle Drive Building, Perry Point, MD 21902 Phone: 410-642-2411 Fax: 410-642-1852 |
News Archive
Opened in March, Detroit Central City is the first community mental health clinic in southeast Michigan to become a specially designated, federally qualified health clinic to integrate mental health care with physical health, or primary care.
New research published in Rheumatology, the international, peer-reviewed scientific journal, has suggested that systemic lupus erythematosus (SLE) patients of African descent and from lower socioeconomic groups face a higher risk of primary cardiac disease. However, those taking anti-malarial drugs reduce their risk.
HealthYes!®, a leading mobile medical screening provider, is offering several new preventive screenings directly focused on heart disease. The new tests include: a six-lead electrocardiogram (EKG), cholesterol finger-stick, and 10-year Framingham Cardiac Risk Score as well as diabetes and liver function testing.
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported the successful completion of its 28-day rat toxicology study of its drug candidate, SPX-106.
KineMed, Inc. and CHDI Foundation, Inc. announced today a collaboration to use KineMed's isotopic labeling and dynamic proteomics platform to investigate the turnover rates of huntingtin protein, a mutant form of which plays a central role in the pathogenesis of Huntington's disease (HD).
› Verified 9 days ago